Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B

Stefan Frohling, Richard F Schlenk, Sabine Kayser, Martina Morhardt, Axel Benner, Konstanze Dohner and Hartmut Dohner
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.